VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

VYCOR MEDICAL INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.07+0.00 (0.00%)

Close on Oct 19, 2026

Earnings

Next report expected Nov 13, 2026, before market open (estimated from past report dates)

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q2 FY2026 Ended Jun 30, 2026	Aug 14, 2026	During market hours	$418.26K	$0.00	$0.00
Q1 FY2026 Ended Mar 31, 2026	May 15, 2026	During market hours	$458.54K	$0.00	$0.00
Q4 FY2025 Ended Dec 31, 2025	Mar 31, 2026	During market hours	–	–	–
Q3 FY2025 Ended Sep 30, 2025	Nov 14, 2025	Before market open	$513.79K	$0.00	$0.00
Q2 FY2025 Ended Jun 30, 2025	Aug 8, 2025	During market hours	$496.35K	$0.00	$0.00
Q1 FY2025 Ended Mar 31, 2025	Apr 15, 2025	During market hours	–	–	–
Q4 FY2019 Ended Dec 31, 2019	Mar 27, 2020	Before market open	–	–	–
Q4 FY2018 Ended Dec 31, 2018	Mar 29, 2019	Before market open	–	–	–
Q4 FY2017 Ended Dec 31, 2017	Mar 30, 2018	Before market open	–	–	–
Q3 FY2017 Ended Sep 30, 2017	Nov 13, 2017	Before market open	–	–	–
Q2 FY2017 Ended Jun 30, 2017	Aug 11, 2017	Before market open	–	–	–

Announcements Vycor Medical filed with the SEC

Parsed from the XBRL in Vycor Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-150 reverse split on Apr 1, 2013
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is VYCO.

Revenue growth1.6% · median 48.1%

Gross margin83.4% · median 35.3%

Operating margin2.7% · median -933.7%

Net margin-3.3% · median -581.6%

Advertisement
300 × 250